| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 01/29/2004 | WO2004009135A2 Conjugates of biocompatible polymers with nuclide activation therapy reagents |
| 01/29/2004 | WO2004009089A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | US20040019201 Refluxing tetracyanoethylene oxide with tetraphenylporphyrin to form (5,10,15,20-tetraphenyl-2,3-(3'-dicyano)cyclopropano -2,3-chlorin); macromolecule intermediates used as chelate compounds; photosensitivity |
| 01/29/2004 | US20040019107 A carbobenzoxy alanyl taurine has potency for treating virus infection, fatigue, allergic reaction, physiological disorders, metabolic disorders, proliferative disorders, immune dysfunctions, drug abuse; use as bactericides |
| 01/29/2004 | US20040019095 N, N'-dimethylated N-confused porphyrins |
| 01/29/2004 | US20040019032 Photodynamic therapy to treat for retinal macular edema (ME) that's more effective and less damaging to tissue surrounding an edematous lesion than laser photocoagulation; ME resulting from diabetes or central or branch retinal vein occulsion |
| 01/29/2004 | US20040018997 Inactivation of West Nile virus and malaria using photosensitizers |
| 01/29/2004 | US20040018960 Antitumor agents; autoimmune diseases; antiarthritic agents; restenosis |
| 01/29/2004 | CA2493252A1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 01/29/2004 | CA2492878A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/28/2004 | EP1383872A2 Genetically modified yt cell line and use thereof |
| 01/28/2004 | EP1383541A1 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/22/2004 | WO2004006954A2 Transdermal botulinum toxin compositions |
| 01/22/2004 | WO2004006765A1 Delivery of therapeutic agent affixed to magnetic particle |
| 01/22/2004 | WO2003097107A3 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 01/22/2004 | WO2003070933A3 Process of cell electrofusion |
| 01/22/2004 | US20040015214 Photodynamic therapy for the treatment of hair loss |
| 01/22/2004 | US20040014737 Porphyron based neuton capture agents for cancer therapy |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040013662 Microbubble compositions and methods for oligonucleotide delivery |
| 01/22/2004 | US20040013639 Injecting radiopaque material together with hydrogel having various visible dyes into the milk ducts for mapping and identifying |
| 01/22/2004 | US20040013562 Reducing the residual solvent content of a biological material to a level effective to protect biological material from ionizing radiation; irradiating biological material with suitable ionizing radiation effective to sterilize |
| 01/22/2004 | US20040013561 Methods for sterilizing recombinant or transgenic material |
| 01/22/2004 | CA2492029A1 Transdermal botulinum toxin compositions |
| 01/21/2004 | EP1382572A1 Ultraviolet-radiation sterilizing fluid apparatus |
| 01/21/2004 | EP1381839A2 Method of imaging cell death in vivo |
| 01/21/2004 | EP1381611A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 01/21/2004 | EP1381571A2 Antioxidants in clusters of structured water |
| 01/20/2004 | US6680301 For transferring dna and/or rna, such as genes, to cells by photochemically inducing the disruption of endosomes and lysosomes |
| 01/20/2004 | US6679841 Fluid collection and monitoring device |
| 01/20/2004 | CA2165984C Compounds for the photodecontamination of pathogens in blood |
| 01/15/2004 | WO2004004769A1 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 01/15/2004 | WO2004004757A1 Treatment for eye disorder |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003064424A3 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 01/15/2004 | WO2003006059A9 Vegfr-1 antibodies to treat breast cancer |
| 01/15/2004 | US20040010218 Injecting an aberrant tissue-selective photosensitizer into the bloodstream, exposing the aberrant tissue to light to activate the photosensitizer which increases the permeablitiy of the vasculature; injecting a chemotherapeutic agent |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009212 .2-.5% of a mucoadhesive polymer of carboxylvinylpolyester (i.e. carbopol or carbomer) and celluloses, 15%-40% of a thermoresponsive polymer having two critical points and a balance of water |
| 01/15/2004 | US20040009180 Transdermal botulinum toxin compositions |
| 01/15/2004 | DE10205510A1 Kakerlak-der Perasit im Menschen seine Bekämpfung und Erkennung als Krebserreger Cockroach-Perasit the people in his fight and recognition as a carcinogen |
| 01/15/2004 | CA2491128A1 Treatment for eye disorder |
| 01/14/2004 | EP1380586A2 Photoactive benzoporphyrin derivatives |
| 01/14/2004 | EP1380305A1 Photodynamic therapy for the enhancement of vascular permeability |
| 01/14/2004 | EP1380295A1 Photosensitiser and method for production thereof |
| 01/14/2004 | EP1379260A2 Methods for treating the inflammatory component of a brain disorder |
| 01/13/2004 | US6677366 Methods, compositions and articles for reducing or preventing the effects of inflammation |
| 01/13/2004 | US6676964 Method for determining the three-dimensional structure of a protein |
| 01/13/2004 | US6676655 Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
| 01/13/2004 | US6676626 Ultrasound assembly with increased efficacy |
| 01/08/2004 | WO2003028628A3 Photosensitizing carbamate derivatives |
| 01/08/2004 | US20040006328 Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
| 01/08/2004 | US20040006254 Pharmaceutically enhanced low-energy radiosurgery |
| 01/08/2004 | US20040006028 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 01/08/2004 | US20040005712 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 01/08/2004 | US20040005680 Activated yeast cell culture for improving immune functions of animals; health foods, drinks and supplement; immunosuppression; immunotherapy |
| 01/08/2004 | US20040005336 Plurality of yeast cells, wherein said plurality of yeast cells have been cultured in the presence of an alternating electric field having a specific frequency and a specific field strength for a period of time sufficient to increase the |
| 01/08/2004 | US20040005335 Oral compositions for HIV-infected subjects |
| 01/08/2004 | US20040005300 By transplanting with hematopoietic stem cells from a donor that are matched at the major histocompatibility complex class I K locus with the recipient hematopoietic microenvironment. |
| 01/08/2004 | DE10204207A1 Mittel zur Anregung des körpereigenen Energieflusses bestehend aus einem um ein Kupferplätchen gelegtes Magnetfeld Means of stimulating the body's energy flow consisting of a magnetic field placed around a Kupferplätchen |
| 01/07/2004 | EP1377274A2 Drug delivery system for hydrophobic drugs |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
| 01/06/2004 | CA2227761C Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 01/02/2004 | EP1375653A1 Dietary supplements for regulating the central nervous system |
| 01/02/2004 | EP1375652A2 Oral compositions for HIV-Infected Subjects |
| 01/02/2004 | EP1375651A2 Oral compositions for white blood cell activation and proliferation |
| 01/02/2004 | EP1375645A1 Yeast cells as dietary supplements for enhancing the immune system |
| 01/02/2004 | EP1375644A1 Dietary supplements for treating hypertension |
| 01/02/2004 | EP1374944A1 Optimization of transcutaneous permeation of compounds |
| 01/02/2004 | EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates |
| 01/02/2004 | EP1374877A1 Anti-aging dietary supplements |
| 01/02/2004 | EP1374876A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
| 01/02/2004 | EP1372786A2 Cytoprotection by phosphotyrosine |
| 01/02/2004 | EP1372742A2 Polymeric imagable brachytherapy seed |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP0979103B1 Light imaging contrast agents |
| 01/01/2004 | US20040002694 System and method for accurate optical treatment of an eye's fundus |
| 01/01/2004 | US20040001860 Dietary supplements for enhancing the immune system |
| 01/01/2004 | US20040001859 Anti-aging dietary supplements |
| 01/01/2004 | US20040001857 Dietary supplements for treating hypertension |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000308A1 Method of photodynamic diagnosis for vascular diseases |
| 12/31/2003 | WO2003087308A3 Use of interleukin-24 to treat ovarian cancer |
| 12/31/2003 | WO2003086460A3 High fluence rate activation of photosensitizers for dermatological applications |
| 12/31/2003 | WO2003061621A3 Dermal application system for aminolevulinic acid-derivatives |
| 12/30/2003 | US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied |
| 12/28/2003 | CA2433985A1 Dietary supplements for treating hypertension |
| 12/28/2003 | CA2432759A1 Dietary supplements beneficial for the gastrointestinal system |
| 12/24/2003 | WO2003063757A3 Auger effect-based cancer therapy method |
| 12/24/2003 | WO2003032900A3 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 12/24/2003 | WO2002060483A3 Perylenequinones for use as photosensitizers and sonosensitizers |
| 12/23/2003 | US6667346 Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones |
| 12/20/2003 | CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals |
| 12/18/2003 | WO2003104237A1 2,7,12,17 alkenyl, aryl and heteroaryl derived from 3,6,13,16-tetraazaporphycene, method, intermediate compound and corresponding utilizations |
| 12/18/2003 | WO2003103722A1 New agents for magnetic imaging method |
| 12/18/2003 | WO2003103585A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 12/18/2003 | WO2003103569A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |